Transforming_VBG
growth_NN
factor-beta_NN
suppresses_VBZ
human_JJ
B_NN
lymphocyte_NN
Ig_NN
production_NN
by_IN
inhibiting_VBG
synthesis_NN
and_CC
the_DT
switch_NN
from_IN
the_DT
membrane_NN
form_NN
to_TO
the_DT
secreted_VBN
form_NN
of_IN
Ig_NN
mRNA_NN
._.

Transforming_VBG
growth_NN
factor-beta_NN
-LRB-_-LRB-
TGF-beta_NN
-RRB-_-RRB-
inhibits_VBZ
B_NN
cell_NN
Ig_NN
secretion_NN
and_CC
reduces_VBZ
B_NN
cell_NN
membrane_NN
Ig_NN
expression_NN
._.

The_DT
addition_NN
of_IN
TGF-beta_NN
to_TO
human_JJ
B_NN
lymphocyte_NN
cultures_NNS
stimulated_VBN
with_IN
Staphylococcus_FW
aureus_FW
Cowan_NN
strain_NN
I_NN
and_CC
IL-2_NN
completely_RB
inhibited_VBD
B_NN
cell_NN
Ig_NN
secretion_NN
-LRB-_-LRB-
greater_JJR
than_IN
90_CD
%_NN
-RRB-_-RRB-
and_CC
decreased_VBD
B_NN
cell_NN
surface_NN
IgM_NN
,_,
IgD_NN
,_,
kappa_NN
L_NN
chain_NN
,_,
and_CC
lambda_NN
L_NN
chain_NN
expression_NN
._.

In_IN
contrast_NN
,_,
TGF-beta_NN
had_VBD
only_RB
minimal_JJ
effects_NNS
on_IN
two_CD
other_JJ
B_NN
cell_NN
membrane_NN
proteins_NNS
,_,
HLA-DR_NN
and_CC
CD20_NN
._.

Internal_JJ
labeling_NN
with_IN
-LCB-_-LRB-
35S-RCB-methionine_NN
and_CC
immunoprecipitation_NN
with_IN
anti-IgM_JJ
,_,
anti-kappa_JJ
,_,
and_CC
anti-lambda_JJ
antibodies_NNS
revealed_VBD
a_DT
striking_JJ
reduction_NN
in_IN
kappa_NN
L_NN
chain_NN
in_IN
the_DT
presence_NN
of_IN
TGF-beta_NN
._.

A_DT
less_RBR
pronounced_JJ
reduction_NN
in_IN
lambda_NN
L_NN
chain_NN
and_CC
microH_NN
chain_NN
was_VBD
also_RB
noted_VBN
._.

Northern_NN
blot_NN
analysis_NN
of_IN
RNA_NN
purified_VBN
from_IN
B_NN
cells_NNS
treated_VBN
with_IN
TGF-beta_NN
for_IN
varying_VBG
time_NN
intervals_NNS
revealed_VBD
a_DT
significant_JJ
decrease_NN
in_IN
steady_JJ
state_NN
kappa_NN
and_CC
lambda_NN
L_NN
chain_NN
mRNA_NN
levels_NNS
._.

Furthermore_RB
,_,
a_DT
significant_JJ
decrease_NN
in_IN
the_DT
switch_NN
from_IN
the_DT
membrane_NN
forms_NNS
of_IN
mu_NN
and_CC
gamma_NN
to_TO
their_PRP$
respective_JJ
secreted_JJ
forms_NNS
was_VBD
noted_VBN
in_IN
the_DT
presence_NN
of_IN
TGF-beta_NN
._.

Nuclear_JJ
run-on_JJ
experiments_NNS
demonstrated_VBD
decreased_VBN
transcription_NN
of_IN
kappa_NN
L_NN
chain_NN
._.

The_DT
effects_NNS
of_IN
TGF-beta_NN
on_IN
two_CD
transcriptional_JJ
regulatory_JJ
factors_NNS
,_,
Oct-2_NN
and_CC
nuclear_JJ
factor_NN
-LRB-_-LRB-
NF_NN
-RRB-_-RRB-
kappa_NN
B_NN
,_,
known_VBN
to_TO
be_VB
important_JJ
in_IN
Ig_NN
gene_NN
transcription_NN
were_VBD
examined_VBN
._.

Oct-2_NN
mRNA_NN
levels_NNS
and_CC
both_CC
Oct-2_NN
and_CC
NF-kappa_NN
B_NN
proteins_NNS
in_IN
nuclear_JJ
extracts_NNS
were_VBD
not_RB
altered_VBN
by_IN
treatment_NN
with_IN
TGF-beta_NN
._.

In_IN
contrast_NN
,_,
levels_NNS
of_IN
the_DT
transcriptional_JJ
factor_NN
AP-1_NN
,_,
which_WDT
is_VBZ
not_RB
known_VBN
to_TO
be_VB
important_JJ
in_IN
B_NN
cell_NN
Ig_NN
production_NN
,_,
were_VBD
reduced_VBN
by_IN
TGF-beta_NN
._.

These_DT
findings_NNS
demonstrate_VBP
that_IN
TGF-beta_NN
decreases_VBZ
B_NN
lymphocyte_NN
Ig_NN
secretion_NN
by_IN
inhibiting_VBG
the_DT
synthesis_NN
of_IN
Ig_NN
mRNA_NN
and_CC
inhibiting_VBG
the_DT
switch_NN
from_IN
the_DT
membrane_NN
form_NN
to_TO
the_DT
secreted_VBN
forms_NNS
of_IN
mu_NN
and_CC
gamma_NN
mRNA_NN
._.

The_DT
mechanism_NN
by_IN
which_WDT
TGF-beta_NN
inhibits_VBZ
Ig_NN
chain_NN
synthesis_NN
is_VBZ
unclear_JJ
although_IN
it_PRP
does_VBZ
not_RB
involve_VB
inhibition_NN
of_IN
the_DT
binding_NN
of_IN
NF-kappa_NN
B_NN
or_CC
Oct-2_NN
to_TO
their_PRP$
respective_JJ
target_NN
sequences_NNS
._.

